Literature DB >> 2897263

In-vitro conversion of blocking type anti-TSH receptor antibody to the stimulating type by anti-human IgG antibodies.

N Amino1, Y Watanabe, H Tamaki, Y Iwatani, K Miyai.   

Abstract

We examined the relationship between blocking type anti-TSH receptor antibody (TRAb) and stimulating type TRAb by trying to convert blocking type TRAb to the stimulatory type in vitro. Immunoglobulins (IgGs) purified from sera of six patients with primary hypothyroidism blocked bovine TSH (100 microU/ml)-induced cAMP production (58.3-82.1% inhibition) in cultured porcine thyroid cells. None of these IgGs showed stimulating activity even after their dilution. In the conversion experiment, thyroid cells were first incubated with these IgGs at 34 degrees C for 30 min and then washed with incubation buffer. They were then incubated with various kinds of anti-human IgG antibodies first for 1.5 h at 4 degrees C and then for 18 h at 34 degrees C, and the cAMP concentrations in the supernatants were measured. All six IgGs showed strong, dose-dependent thyroid-stimulating activity after addition of antibodies against human whole IgG, or Fab or Fc fragments of IgG. The Fab or F(ab')2 fragments of goat anti-human IgG antibody also had these converting activities, although less than whole IgG. Addition of normal IgG in the first incubation or anti-human IgG antibody alone had no thyroid-stimulating activity. Anti-human IgA or IgM antibodies did not have these converting activities. These results show that blocking type anti-TSH receptor antibodies can be converted to the stimulating type by anti-human IgG antibodies in vitro. The results suggest that the blocking and stimulating types bind to the same epitope(s) of TSH-receptor related antigens. The same anti-TSH receptor antibody may act as a stimulator or blocker by the influence of other factors, such as anti-idiotype antibody.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2897263     DOI: 10.1111/j.1365-2265.1987.tb01192.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  4 in total

1.  Rapid bioassay for detection of thyroid-stimulating antibodies using cyclic adenosine monophosphate-gated calcium channel and aequorin.

Authors:  Naohiro Araki; Mitsuru Iida; Nobuyuki Amino; Shinji Morita; Akane Ide; Eijun Nishihara; Mitsuru Ito; Jun Saito; Tetsuo Nishikawa; Kiyonori Katsuragi; Akira Miyauchi
Journal:  Eur Thyroid J       Date:  2015-02-19

2.  Binding domains of stimulatory and inhibitory thyrotropin (TSH) receptor autoantibodies determined with chimeric TSH-lutropin/chorionic gonadotropin receptors.

Authors:  Y Nagayama; H L Wadsworth; D Russo; G D Chazenbalk; B Rapoport
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

3.  Scintigraphic findings of the thyroid in hypothyroid patients with blocking-type TSH-receptor antibodies.

Authors:  K Kasagi; H Hatabu; S Miyamoto; R Takeuchi; T Misaki; H Sakahara; Y Iida; J Konishi
Journal:  Eur J Nucl Med       Date:  1994-09

4.  The Presence of Thyroid-Stimulation Blocking Antibody Prevents High Bone Turnover in Untreated Premenopausal Patients with Graves' Disease.

Authors:  Sun Wook Cho; Jae Hyun Bae; Gyeong Woon Noh; Ye An Kim; Min Kyong Moon; Kyoung Un Park; Junghan Song; Ka Hee Yi; Do Joon Park; June-Key Chung; Bo Youn Cho; Young Joo Park
Journal:  PLoS One       Date:  2015-12-09       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.